FDA Mobile App Guidance Focuses on Risk, Calls for “Enforcement Discretion”
Sept. 30, 2013 – Pharmaceutical companies that develop mobile applications should pay close attention to the details and examples listed in the FDA’s final guidance on mobile medical applications...
View ArticleDale Cooke: New Product Name Placement Draft Guidance Rights Wrongs from 2012...
Nov. 25, 2013 – The FDA published a Federal Register notice (2013-27770 (1)) on Nov. 20 regarding the availability of new draft guidance on product name placement, size and prominence in advertising...
View ArticleFTC Calls for Data Broker Legislation To Protect Consumers
May 29, 2014 – The Federal Trade Commission (FTC) released a report May 27 in which it asks Congress to consider legislation that would require data brokers to provide consumers with access to their...
View ArticleCoalition Panel: Data Regulation Focus Shifting from Privacy to Security
Sept. 29, 2014 – The federal government’s efforts to severely limit the ability of industry to gather and use online data have shifted away from data privacy and toward data security, according to...
View ArticleKaiser Poll: DTC Ads Have High Profile, But Mixed Reviews
Oct. 30, 2015 – The drug industry may have additional work to do to improve the public’s perception of its advertising, according to Kaiser Health Tracking Poll findings reported Oct. 28. Although a...
View ArticleFDA Will Study Consumer and HCP Ability to Identify Deceptive Drug Promotion
Jan. 4, 2017 – The FDA will examine whether consumers and health care professionals (HCPs) can identify deceptive claims in prescription drug promotion, according to a notice published in today’s...
View ArticleFDA Appears Subject to Some Exemptions from Hiring Freeze
Feb. 13, 2017 – A memo sent to Department of Health and Human Services (HHS) division heads last week from HHS Acting Deputy Secretary Colleen Barros attempts to better define exemptions from the...
View ArticleCitizen Petition Calls on FDA to Stay Final Rule Establishing “Totality of...
Feb. 24, 2017 – The FDA recently published a final rule on intended use and adequate directions for use that establishes a not-previously-announced “totality of the evidence” standard and is in...
View ArticleIndustry Peacekeeping with President Trump Holds Promise But Portends Danger
By John Kamp, Executive Director, Coalition for Healthcare Communication [Editor’s Note: This “The Final Word” column appeared in the February 2017 edition of MedAdNews and is reprinted with...
View ArticleWhat Medical Marketers Can Expect from President Trump, Republican-led Congress
April 24, 2017 – There is no doubt that the Trump administration is likely to change health policy, but the questions that remain to be answered are exactly what those changes will be and how they will...
View Article
